Clinical Trial Update: High-dose Simvastatin for Aneurysmal Subarachnoid Haemorrhage [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluating high-dose simvastatin for aneurysmal subarachnoid hemorrhage has completed. The study was conducted by the Chinese University of Ho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Subarachnoid Hemorrhage | Phase 2, Phase 3 | Status: COMPLETED